Lyme disease vaccine shows 70% efficiency in trial

3 Video Views·Mar 31, 2026

Biotech companies Valneva and Pfizer announced results from the Phase three trial of a Lyme disease vaccine candidate that shows more than 70% efficiency in preventing the disease.

Stay informed about Massachusetts news, weather, breaking news and investigations! Follow WWLP on our website and social channels:

https://www.wwlp.com/
https://www.youtube.com/user/wwlp
https://www.facebook.com/WWLP22News
https://twitter.com/WWLP22News
https://www.instagram.com/wwlp22news/